Table 3 Results of genotyping studies in relation to the phylogenetic group
B2 (n = 40) | D (n = 19) | Pvalue* | |||||||
|---|---|---|---|---|---|---|---|---|---|
Genes | APEC n = 20 | NMEC n = 6 | Septicemic/UPEC n = 14 | TOTAL B2 n = 40 | APEC n = 1 | NMEC n = 9 | UPEC-Sepsis n = 9 | TOTAL D n = 19 | B2 vs D |
FimAv MT78 | 2/20(10%) | 1/6(16%) | 2/14(14%) | 5/40(12,5%) | 0 | 5/9(55%) | 8/9(89%) | 13/19(68%) | + (0.000) |
papGII | 20/20(100%) | 5/6(83%) | 14/14(100%) | 39/40 (95%) | 1/1(100%) | 6/9(67%) | 3/9 (33%) | 10/19(53%) | + (0.000) |
sat | 0 | 2/6(33%) | 2/14(14%) | 4/40(10%) | 0 | 8/9(89%) | 9/9(100%) | 17/19(89%) | + (0.000) |
tsh | 6/20(30%) | 1/6(17%) | 2/14(14%) | 9/40(22,5%) | 1/1(100%) | 0 | 0 | 1/19(5%) | - (0.096) |
iro N | 20/20(100%) | 4/6(67%) | 10/14(71%) | 34/40(50%) | 1/1(100%) | 1/9(11%) | 0 | 2/19(10,5%) | + (0.000) |
cva C | 12/20(60%) | 3/6(50%) | 6/14(43%) | 21/40(52,5%) | 1/1(100%) | 0 | 0 | 1/19(5%) | + (0.000) |
iss | 19/20(95%) | 3/6(50%) | 8/14(57%) | 30/40(75%) | 1/1(100%) | 0 | 0 | 1/19(5%) | + (0.000) |